Busulfan, fludarabine, ATG, TLI
( DrugBank: Busulfan, Fludarabine / KEGG DRUG: Busulfan, Fludarabine phosphate, Fludarabine )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 65 | Primary immunodeficiency | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 284 | Diamond-Blackfan anemia | 1 |
65. Primary immunodeficiency
Clinical trials : 798 / Drugs : 585 - (DrugBank : 118) / Drug target genes : 100 - Drug target pathways : 216
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
284. Diamond-Blackfan anemia
Clinical trials : 39 / Drugs : 95 - (DrugBank : 35) / Drug target genes : 34 - Drug target pathways : 131
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|